(-0.08%) 5 304.00 points
(-0.02%) 40 134 points
(-0.12%) 18 482 points
(1.39%) $82.48
(-0.47%) $1.710
(0.76%) $2 229.60
(-0.36%) $24.66
(0.08%) $910.45
(0.42%) $0.927
(0.75%) $10.85
(0.21%) $0.793
(-0.21%) $92.25
5 days till quarter result
(bmo 2024-04-02)
Expected move: +/- 9.89%
Live Chart Being Loaded With Signals
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform...
Stats | |
---|---|
Today's Volume | 79 707.00 |
Average Volume | 11 048.00 |
Market Cap | 5.56M |
EPS | $0 ( 2024-03-26 ) |
Next earnings date | ( $0 ) 2024-04-02 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.850 |
ATR14 | $0.113 (1.53%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-18 | Choong Choon Hau | Buy | 54 132 | Common Stock |
2024-03-18 | Choong Choon Hau | Sell | 0 | Convertible Promissory Note |
2023-10-25 | Natan David | Buy | 16 250 | Common Stock |
2023-10-25 | Mcmurdo Matthew Charles | Buy | 16 250 | Common Stock |
2023-10-25 | Greenberg Eric Howard | Buy | 16 250 | Common Stock |
INSIDER POWER |
---|
-84.49 |
Last 97 transactions |
Buy: 7 283 197 | Sell: 21 672 130 |
Titan Pharmaceuticals Inc Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations | |
---|---|
NETE | -0.806 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Titan Pharmaceuticals Inc Financials
Annual | 2022 |
Revenue: | $60 000.00 |
Gross Profit: | $-136 000 (-226.67 %) |
EPS: | $-0.760 |
Q3 | 2023 |
Revenue: | $4 000.00 |
Gross Profit: | $-23 000.00 (-575.00 %) |
EPS: | $-0.0225 |
Q2 | 2023 |
Revenue: | $1 000.00 |
Gross Profit: | $-441 000 (-44 100.00 %) |
EPS: | $-0.110 |
Q1 | 2023 |
Revenue: | $98 000.00 |
Gross Profit: | $55 000.00 (56.12 %) |
EPS: | $-0.110 |
Financial Reports:
No articles found.
Titan Pharmaceuticals Inc
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program (TP-2021) for use in combination with ProNeura technology for the treatment of chronic pruritus; nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder; and other programs, including HIV preventative therapeutic and a contraceptive from a single ProNeura implant for women and adolescent girls. The company was incorporated in 1992 and is based in South San Francisco, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators